Laroche, Audrey <br/><br/>
Heterogeneous Mechanisms of Secondary Resistance and Clonal Selection in Sarcoma during Treatment with Nutlin.  [electronic resource] 

 -  PloS one  2015 
 - e0137794 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0137794  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Autophagy--drug effects<br/>Cell Cycle Checkpoints--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Clone Cells--drug effects<br/>Drug Resistance, Neoplasm--genetics<br/>Gene Expression Profiling<br/>Humans<br/>Imidazoles--pharmacology<br/>Mutation<br/>Ploidies<br/>Proto-Oncogene Proteins c-mdm2--metabolism<br/>Pyrrolidines--pharmacology<br/>Sarcoma--drug therapy<br/>Sequence Analysis, RNA<br/>Signal Transduction--drug effects<br/>Tumor Suppressor Protein p53--genetics<br/>para-Aminobenzoates--pharmacology